Serometrix

Serometrix

Biotechnology, 732 Pittsford Victor Rd, Pittsford, New York, 14534, United States, 1-10 Employees

serometrix.com

  • LinkedIn

phone no Phone Number: 15*********

Who is SEROMETRIX

Serometrix is an in silico Drug Discovery company that delivers novel families of targeted lead stage molecules for development by strategic partners. The proprietary Serometrix discovery...

Read More

map
  • 732 Pittsford Victor Rd, Pittsford, New York, 14534, United States Headquarters: 732 Pittsford Victor Rd, Pittsford, New York, 14534, United States
  • 2004 Date Founded: 2004
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SEROMETRIX

Serometrix Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Serometrix

Answer: Serometrix's headquarters are located at 732 Pittsford Victor Rd, Pittsford, New York, 14534, United States

Answer: Serometrix's phone number is 15*********

Answer: Serometrix's official website is https://serometrix.com

Answer: Serometrix's revenue is $1 Million to $5 Million

Answer: Serometrix's SIC: 8731

Answer: Serometrix's NAICS: 541715

Answer: Serometrix has 1-10 employees

Answer: Serometrix is in Biotechnology

Answer: Serometrix contact info: Phone number: 15********* Website: https://serometrix.com

Answer: Serometrix is an in silico Drug Discovery company that delivers novel families of targeted lead stage molecules for development by strategic partners. The proprietary Serometrix discovery platform identifies and emulates wild type protein interactions, providing detailed biological knowledge and delivering synthetic lead stage molecules for licensure and/or co-development. The company offers significant value to the drug discovery and development process by providing: * a proprietary in silico method for identifying protein-protein interaction "hot spots", complementing x-ray crystallography and antibody mapping techniques * a proprietary in silico method that yields initial regulatory prototype compounds (wild type ligands) for orthosteric and allosteric manipulation of these "hot spots" * an iterative in silico/in vitro strategy which helps define the structure activity relationship (SAR) at, or near, these biologically relevant "hot spots" * a family of "induced fit & structure optimized" lead stage molecules which can be further preclinically developed, or utilized by development partners to initiate more efficient and commercially relevant HTS strategies * an all encompassing breadth of associated biological IP, including targets, ligand families, and target specific biological processes which can be used by development partners for tremendous competitive advantage

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access